Antimelanoma differentiation‐associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis
Takashi Matsushita(Kanazawa University), K. Takehara(Kanazawa University), Manabu Fujimoto(Osaka Gakuin University), Momoko Tennichi(Kanazawa University), Yoshinobu Okamoto(Kanazawa University), Akihiro Murakami(Medical & Biological Laboratories (Japan)), Minoru Hasegawa(University of Fukui), Y. Hamaguchi(Kanazawa University), K. Mizumaki(Kanazawa University), Masanobu Kano(Keio University), Akiko Takeuchi(Kanazawa University), N. YAGI(Kanazawa University), M. Kuwana(Nippon Medical School)
Cited by 186
Related Papers
A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory Responses
|Immunity|2008|1.2k
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
|Journal of Clinical Investigation|2008|907
Idiopathic inflammatory myopathies
|Nature Reviews Disease Primers|2021|683
Connective Tissue Growth Factor Gene Expression in Tissue Sections From Localized Scleroderma, Keloid, and Other Fibrotic Skin Disorders
|Journal of Investigative Dermatology|1996|438